0001193125-22-260777.txt : 20221110 0001193125-22-260777.hdr.sgml : 20221110 20221011181459 ACCESSION NUMBER: 0001193125-22-260777 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20221011 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tyra Biosciences, Inc. CENTRAL INDEX KEY: 0001863127 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831476348 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 2656 STATE STREET CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: (619) 728-4760 MAIL ADDRESS: STREET 1: 2656 STATE STREET CITY: CARLSBAD STATE: CA ZIP: 92008 CORRESP 1 filename1.htm CORRESP

Tyra Biosciences, Inc.

2656 State Street

Carlsbad, CA 92008

October 11, 2022

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

  Re:

Tyra Biosciences, Inc.

Registration Statement on Form S-3

File No. 333-267712

To the addressees set forth above:

Pursuant to Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, on behalf of Tyra Biosciences, Inc., respectfully requests that the effective date of the Registration Statement on Form S-3 referred to above be accelerated so that it will become effective at 4:00 P.M. Eastern Time on October 13, 2022, or as soon as practicable thereafter.

If you have any questions or require additional information, please contact Matthew T. Bush, Esq. of Latham & Watkins LLP at (858) 523-3962. Thank you for your assistance and cooperation in this matter.

 

Very truly yours,
TYRA BIOSCIENCES, INC.
By:  

/s/ Todd Harris, Ph.D.

  Todd Harris, Ph.D.
  President and Chief Executive Officer

 

cc:

Ali Fawaz, Tyra Biosciences, Inc.

Matthew T. Bush, Latham & Watkins LLP